The present invention relates to the use of novel pyrrolopyrazine derivatives of formula I:
wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.
AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF BETA-SECRETASE
申请人:Malamas Michael Sotirios
公开号:US20090048320A1
公开(公告)日:2009-02-19
The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
Highly efficient green synthesis of α-hydroxyphosphonates using a recyclable choline hydroxide catalyst
作者:Reddi Mohan Naidu Kalla、Yu Zhang、Il Kim
DOI:10.1039/c6nj03948k
日期:——
Choline hydroxide has been found to be an efficient basic ionic liquid catalyst for the synthesis of α-hydroxyphosphonates. Hydrophosphonylation of aldehydes was performed via the nucleophilic addition of diethylphosphite to aldehydic carbonyl compounds, in the presence of choline hydroxide under neat as well as solvent conditions. A wide array of substrates, including aromatic, fused aromatic, and
Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase
申请人:Malamas Michael Sotirios
公开号:US20100168194A1
公开(公告)日:2010-07-01
The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.